André de Lange

Involved in a number of prominent merger and take-over transactions, including transactions effected by schemes of arrangement, and hostile take-overs.

Involved in a number of listings of companies on the JSE and the alternative exchange of the JSE.

Advising a number of large listed company groups in complying with the Companies Act and King IV.

Advised Remgro in their facilitation of Mediclinic's acquisitions of interests in Spire and Al Noor in the United Kingdom.

Advising Remgro in the issue of exchangeable bonds listed on the Frankfurt Stock Exchange.

Advised Remgro in their R9billion rights issue.

PSG Group

Advising Mediclinic in the acquisition by Remgro and Mediterranean Shipping Company of joint control over Mediclinic and the delisting of Mediclinic from the LSE and the JSE.

Providing private hospital regulatory advice to Mediclinic, including representing Mediclinic in the Competition Commission's Healthcare Market Inquiry and in their submissions in respect of the proposed National Health Insurance.

Advising PSG Group in its unbundling of its shareholding in Capitec Bank and the subsequent unbundling of substantially all PSG Group' listed investments to its shareholders, and the delisting of PSG Group from the JSE.

Advising Volaris (a subsidiary of Canadian Constellation Software) in its acquisition of control over JSE listed Adapt IT.

Advising Swiss incorporated and listed Richemont in the termination of its depositary receipt programme on the JSE and the listing of it’s A shares and A warrants as a secondary listing on the JSE.